Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases

Molecular and Cellular Neurosciences
Maria Xilouri, Leonidas Stefanis

Abstract

One of the main pathways of lysosomal proteolysis is chaperone-mediated autophagy (CMA), which represents a selective mechanism for the degradation of specific soluble proteins within lysosomes. Along with the other two lysosomal pathways, macro- and micro-autophagy, CMA contributes to cellular quality control through the removal of damaged or malfunctioning proteins. The two intrinsic characteristics of CMA are the selective targeting and the direct translocation of substrate proteins into the lysosomal lumen, in a fine-tuned manner through the orchestrated action of a chaperone/co-chaperone complex localized both at the cytosol and the lysosomes. Even though CMA was originally identified as a stress-induced pathway, basal CMA activity is detectable in most cell types analyzed so far, including neurons. Additionally, CMA activity declines with age and this may become a major aggravating factor contributing to neurodegeneration. More specifically, it has been suggested that CMA impairment may underlie the accumulation of misfolded/aggregated proteins, such as alpha-synuclein or LRRK2, whose levels or conformations are critical to Parkinson's disease pathogenesis. On the other hand, CMA induction might accelerate clearance of pa...Continue Reading

References

Aug 1, 1990·Trends in Biochemical Sciences·J F Dice
Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J M Backer, J F Dice
May 19, 1997·The Journal of Cell Biology·F A AgarraberesJ F Dice
Aug 7, 1998·Molecular Biology of the Cell·A M CuervoJ F Dice
May 1, 1999·Archives of Biochemistry and Biophysics·K FurutaJ T August
Oct 23, 2003·Human Molecular Genetics·Zheng-Hong QinMarian DiFiglia
May 20, 2004·Kidney International·Sira SooparbHarold A Franch
Aug 28, 2004·Molecular Biology of the Cell·Roberta KiffinAna Maria Cuervo
Feb 1, 2005·Lancet·William P GilksNicholas W Wood
May 17, 2005·Immunity·Delu ZhouJanice S Blum
Sep 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Atsushi IwataRon R Kopito
Apr 6, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ashish C MasseyAna Maria Cuervo
Jul 29, 2006·Autophagy·Patrick F FinnJ Fred Dice
Aug 19, 2006·The EMBO Journal·Susmita KaushikAna Maria Cuervo
Feb 8, 2007·Journal of Cell Science·Roberta KiffinAna Maria Cuervo
Dec 13, 2007·The Journal of Biological Chemistry·Yongjun WangMark J Czaja
Mar 14, 2008·Molecular Biology of the Cell·Susmita KaushikAna Maria Cuervo
Jul 23, 2008·Molecular and Cellular Biology·Urmi BandyopadhyayAna Maria Cuervo
Jun 11, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Heng LiuXiulian Sun
Aug 6, 2009·Human Molecular Genetics·Yipeng WangEckhard Mandelkow
Aug 22, 2009·Nature Reviews. Molecular Cell Biology·Barth D Grant, Julie G Donaldson
Dec 23, 2009·The Journal of Cell Biology·Leslie Michels ThompsonJoan S Steffan
Jun 10, 2010·Human Molecular Genetics·Cara RothenbergMervyn J Monteiro
Aug 11, 2010·Archives of Neurology·Lydia Alvarez-ErvitiAnthony H V Schapira
Aug 24, 2010·Autophagy·Cara Rothenberg, Mervyn J Monteiro
Aug 28, 2010·Molecular Cell·Urmi BandyopadhyayAna Maria Cuervo
Jan 18, 2011·Neurochemistry International·C Marin, E Aguilar
Feb 7, 2012·Neurochemistry International·Eisuke DohiNorio Sakai
Sep 4, 2012·Molecular Neurobiology·Maria XilouriLeonidas Stefanis
Oct 17, 2012·PloS One·Lin QiZheng-Hong Qin
Mar 5, 2013·Nature Neuroscience·Samantha J OrensteinAna Maria Cuervo
Apr 16, 2013·Nature Chemical Biology·Jaime AnguianoAna Maria Cuervo
Jun 13, 2013·Brain : a Journal of Neurology·Maria XilouriLeonidas Stefanis

❮ Previous
Next ❯

Citations

May 7, 2015·Biomolecules·Belém Sampaio-Marques, Paula Ludovico
Jan 20, 2016·Expert Reviews in Molecular Medicine·Mahmoud IranpourSaeid Ghavami
Nov 18, 2015·Journal of Molecular Neuroscience : MN·Paola RusminiAngelo Poletti
Sep 24, 2015·Neurobiology of Disease·Emily M RochaOle Isacson
Jul 24, 2015·Neurology·Daniel L Kenney, Eduardo E Benarroch
Mar 10, 2015·Molecular and Cellular Neurosciences·George K Tofaris, Anthony H V Schapira
May 19, 2016·Cell Biology International·Yufei YangAihua Chen
Oct 21, 2016·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Aileen R Ariosa, Daniel J Klionsky
Sep 28, 2016·PeerJ·P Githure M'Angale, Brian E Staveley
Aug 18, 2018·Nature Reviews. Drug Discovery·Barry BolandMark J Millan
May 21, 2015·Nature Reviews. Neuroscience·Fiona M MenziesDavid C Rubinsztein
Apr 12, 2016·Journal of Parkinson's Disease·Andrea BomanPer Svenningsson
Jul 7, 2017·Frontiers in Molecular Neuroscience·Paola RusminiAngelo Poletti
Jul 11, 2018·Cell Death & Disease·Natascha FussiGünter U Höglinger
Aug 28, 2020·Frontiers in Cell and Developmental Biology·Erik L FriesenSuneil K Kalia
Jun 28, 2018·Neurotoxicity Research·Manish Kumar TripathiMahendra Pratap Singh
Nov 30, 2016·Frontiers in Oncology·Seyma DemirsoyPatrizia Agostinis
Jan 11, 2020·Frontiers in Neuroscience·Federica AlbaneseMichele Morari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Related Papers

Methods in Enzymology
S Kaushik, Ana Maria Cuervo
Trends in Endocrinology and Metabolism : TEM
Ana Maria Cuervo
© 2022 Meta ULC. All rights reserved